Market revenue in 2023 | USD 13.1 million |
Market revenue in 2030 | USD 52.6 million |
Growth rate | 21.9% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, NGS Commercial Software |
Key market players worldwide | Bio-Rad Laboratories Inc, DNAnexus, Qiagen NV, DNAstar, Pacific Biosciences of California Inc, Eurofins Scientific SE, Illumina Inc, PierianDx, Agilent Technologies Inc, Roche Holding AG, Alphabet Inc Class A, Thermo Fisher Scientific Inc, Golden Helix, Scigenom Labs, Genuity Science, Fabric Genomics (formerly Omicia), Congenica, Precigen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next-generation sequencing data analysis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 54.2% in 2023. Horizon Databook has segmented the Brazil next-generation sequencing data analysis market based on services, ngs commercial software covering the revenue growth of each sub-segment from 2018 to 2030.
A number of NGS-based research studies conducted in Brazil created a demand for NGS data analysis and storage solutions in this country. A report published in April 2019 involved the use of NGS technology by Brazilian researchers to generate the complete or near full-length genome of HIV to predict the HIV-1 genetic diversity in Brazil.
The usage of this technology improved the characterization of intra- and inter-host diversity of this virus, and high sensitivity was achieved in the detection of recombinant viral forms, thereby representing major improvements related to NGS application.
Such research studies are anticipated to expand awareness about NGS technology in Brazil. Moreover, new NGS technologies are providing unprecedented benefits for personalized medicine. In addition, during the pandemic, Brazil healthcare authorities were focused on sequencing technologies for precise tracking of COVID-19.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil next-generation sequencing data analysis market , including forecasts for subscribers. This country databook contains high-level insights into Brazil next-generation sequencing data analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account